| methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg. |
NCT00866996: Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder |
|
|
| Completed | 4 | 1323 | US | Methylphenidate extended-release; Atomoxetine | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Attention Deficit Hyperactivity Disorder | | 12/03 | | |
NCT00302367: An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects |
|
|
| Completed | 4 | 20 | US | OROS methylphenidate hydrochloride, immediate release methylphenidate hydrochloride | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Healthy Volunteers | 04/04 | 04/04 | | |
NCT00663442: Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 48 | US | OROS methylphenidate, Concerta | University of Illinois at Chicago, National Institute of Mental Health (NIMH) | ADHD | 11/04 | 11/04 | | |
| Completed | 4 | 30 | US | atomoxetine (Strattera) | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | ADHD NOS | | 07/05 | | |
NCT00181987: Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder |
|
|
| Completed | 4 | 29 | US | methylphenidate HCl (Concerta) | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | ADHD, Bipolar Disorder | 08/05 | 08/05 | | |
NCT00302354: A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults |
|
|
| Completed | 4 | 50 | US | OROS methylphenidate HCl, SODAS methylphenidate HCl | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Healthy Volunteers | 09/05 | 09/05 | | |
NCT00318981: Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD |
|
|
| Completed | 4 | 40 | US | Concerta | University of Maryland, College Park, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Children's National Research Institute | Adult ADHD | | 12/06 | | |
NCT00302458: A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults |
|
|
| Completed | 4 | 44 | US | OROS-Methylphenidate, Concerta, OROS MPH, Immediate Release Methylphenidate, IR MPH, Ritalin, Placebo | Massachusetts General Hospital, Ortho-McNeil Janssen Scientific Affairs, LLC | Healthy | 06/07 | 06/07 | | |
NCT00518232: A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder |
|
|
| Completed | 4 | 520 | RoW | OROS-methylphenidate | Johnson & Johnson Taiwan Ltd | Attention Deficit Hyperactivity Disorder | 06/07 | 06/07 | | |
NCT00181571: A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder |
|
|
| Completed | 4 | 297 | US | methylphenidate HCl (Concerta), Concerta, Placebo | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | ADHD | 08/07 | 08/07 | | |
NCT00323947: Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy |
|
|
| Completed | 4 | 33 | US | Extended Release Methylphenidate (OROS-Methylphenidate), Concerta | Boston Children's Hospital, National Institute of Mental Health (NIMH) | Attention Deficit Disorder With Hyperactivity, Epilepsy | 11/07 | 11/07 | | |
NCT00302406: Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate |
|
|
| Completed | 4 | 50 | US | methylphenidate hydrochloride, OROS methylphenidate hydrochloride (CONCERTA) | Massachusetts General Hospital, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Attention Deficit Hyperactivity Disorder | 11/07 | 11/07 | | |
NCT00585910: Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD |
|
|
| Completed | 4 | 94 | US | Atomoxetine and OROS Methylphenidate, Strattera, Concerta | Massachusetts General Hospital, Ortho-McNeil Janssen Scientific Affairs, LLC | ADHD, Attention Deficit Hyperactivity Disorder | 12/07 | 12/07 | | |
CHOP, NCT00530257: Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory |
|
|
| Completed | 4 | 30 | US | Placebo, OROS-methylphenidate, Concerta, Osmotic-Release Oral System -methylphenidate | Children's Hospital of Philadelphia, Ortho-McNeil Janssen Scientific Affairs, LLC | Attention Deficit Hyperactivity Disorder | 06/08 | 06/08 | | |
NCT00758160 / 2015-001216-35: The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 296 | RoW | OROS Methylphenidate | Johnson & Johnson Taiwan Ltd, Johnson & Johnson Taiwan Ltd | Attention Deficit Disorder With Hyperactivity | 06/08 | 06/08 | | |
NETADHD, NCT00757029: Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) |
|
|
| Completed | 4 | 150 | RoW | norepinephrine transporter polymorphism,, OROS methylphenidate (Concerta) monopharmacotherapy, dose : 18-54mg, duration : 8 weeks, genotyping : norepinephrine transporter (SLC6A2) polymorphism | Hallym University Medical Center | Attention Deficit Disorder With Hyperactivity, Methylphenidate, Pharmacogenetics | 08/08 | 08/10 | | |
NCT00842127: Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) |
|
|
| Completed | 4 | 150 | RoW | OROS-methylphenidate (Concerta), Concerta | Bundang CHA Hospital, Hallym University Medical Center | Attention Deficit Hyperactivity Disorder | 08/08 | 08/08 | | |
NCT00783835: Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 60 | RoW | Long-Acting Methylphenidate, Concerta | Janssen-Cilag Farmaceutica Ltda. | Attention Deficit Hyperactivity Disorder | 10/08 | 10/08 | | |
NCT00593112: Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate |
|
|
| Completed | 4 | 39 | US | OROS methylphenidate, Concerta, No intervention | Massachusetts General Hospital | ADHD | 05/09 | 05/09 | | |
NCT01238822: Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 96 | US | Methylphenidate, Concerta, placebo | Children's Hospital Medical Center, Cincinnati | Attention Deficit Hyperactivity Disorder | 06/09 | 06/09 | | |
NCT00799409: Lab School Day Study for CONCERTA of Older Children With ADHD |
|
|
| Completed | 4 | 78 | US | Placebo/ CONCERTA (methylphenidate HCl), CONCERTA (methylphenidate HCl) / Placebo | Ortho-McNeil Janssen Scientific Affairs, LLC | Attention Deficit Hyperactivity Disorder | 06/09 | 06/09 | | |
| Completed | 4 | 89 | US | CONCERTA (methylphenidate HCl) or placebo | Ortho-McNeil Janssen Scientific Affairs, LLC | Attention Deficit Hyperactivity Disorder | 06/09 | 06/09 | | |
NCT01012622: An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 142 | RoW | Osmotic Release Oral System (OROS) Methylphenidate Hydrochloride | Janssen Korea, Ltd., Korea | Attention Deficit Disorder With Hyperactivity | 08/09 | 08/09 | | |
NCT00889915: Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) |
|
|
| Completed | 4 | 228 | US | Methylphenidate transdermal system, Daytrana, Lisdexamfetamine dimesylate, Vyvanse, Osmotic-release oral system methylphenidate (OROS MPH), Concerta, Mixed amphetamine salts extended release, Adderall XR | Duke University, National Institute of Mental Health (NIMH) | Attention Deficit Disorder With Hyperactivity | 12/09 | 12/09 | | |
NCT00937040: Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 357 | US | OROS MPH, Placebo, OROS MPH Tablets, Placebo Tablets | Ortho-McNeil Janssen Scientific Affairs, LLC | Attention Deficit Disorder With Hyperactivity | 02/10 | 02/10 | | |
NCT00862108: Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD) |
|
|
| Unknown status | 4 | 50 | RoW | Methylphenidate, Concerta OROS, Metadate CD, Penid | Seoul National University Hospital, Korea Health Industry Development Institute | Attention Deficit Hyperactivity Disorder | 03/10 | 03/10 | | |
NCT01060150 / 2015-001084-39: An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 115 | RoW | OROS Methylphenidate HCl, Concerta | Janssen Korea, Ltd., Korea, Janssen Korea Ltd | Attention Deficit Disorder With Hyperactivity | 04/10 | 04/10 | | |
NCT00931398: Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate |
|
|
| Withdrawn | 4 | 0 | US | methylphenidate HCl (Concerta), Concerta, Placebo | University of Pittsburgh, Ortho-McNeil Janssen Scientific Affairs, LLC | Attention-Deficit/Hyperactivity Disorder (ADHD) | 04/10 | 04/10 | | |
NCT01933880: A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants |
|
|
| Completed | 4 | 194 | RoW | Osmotic Release Oral System Methylphenidate Hydrochloride (OROS-MPH), No intervention | Xian-Janssen Pharmaceutical Ltd. | Attention Deficit Hyperactivity Disorder (ADHD) | 11/10 | 11/10 | | |
NCT01065259: Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children |
|
|
| Completed | 4 | 262 | RoW | OROS MPH, Concerta, Atomoxetine, Strattera | Peking University | Attention Deficit Hyperactivity Disorder | 12/10 | 12/10 | | |
NCT00778310: Neuroimaging of the Effects of Concerta in the Treatment of ADHD |
|
|
| Completed | 4 | 76 | US | methylphenidate-OROS, Placebo | The University of Texas Health Science Center at San Antonio, Ortho-McNeil Janssen Scientific Affairs, LLC | Attention Deficit Disorder With Hyperactivity | 12/10 | 12/10 | | |
NCT00181714: Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta |
|
|
| Completed | 4 | 203 | US | methylphenidate HCl (Concerta), Concerta | Massachusetts General Hospital, Ortho-McNeil Janssen Scientific Affairs, LLC | ADHD | 01/11 | 01/11 | | |
| Terminated | 4 | 23 | Europe | Atomoxetine, Strattera, LY139603, Osmotic-release oral system methylphenidate, Placebo | Eli Lilly and Company | Attention Deficit Hyperactivity Disorder | 05/11 | 05/11 | | |
| Completed | 4 | 69 | Europe | methylphenidate, Concerta, Ritaline, placebo | University Hospital, Lille | Parkinson's Disease, Gait Disorders, Neurologic, Dementia | 12/11 | 12/11 | | |
NCT01063153: Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials |
|
|
| Completed | 4 | 71 | US | Osmotic Release Methylphenidate, Concerta | Massachusetts General Hospital, ElMindA Ltd | Attention Deficit Hyperactivity Disorder | 02/12 | 02/12 | | |
NCT01393574: Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties |
|
|
| Unknown status | 4 | 46 | RoW | Melatonin, Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta | Assaf-Harofeh Medical Center | Attention Deficit Hyperactivity Disorder, Sleep Onset Insomnia | 06/12 | | | |
| Completed | 4 | 168 | US | Methylphenidate HCl, Concerta, Risperidone, Risperdal, Parent Management Training (PMT), Community Parent Education Program, Placebo | Michael Aman, National Institute of Mental Health (NIMH) | Attention Deficit Disorder With Hyperactivity | 11/12 | 11/12 | | |
NCT01727414: Attention Deficit Disorder Medication Response Study |
|
|
| Completed | 4 | 171 | US | OROS-Methylphenidate and placebo for inattentive type pts, concerta, OROS-Methylphenidate and placebo for combined type pts | Children's Hospital Medical Center, Cincinnati, National Institute of Mental Health (NIMH) | ADHD - Inattentive Type, ADHD - Combined Type | 07/13 | 07/14 | | |
NCT01552915: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder |
|
|
| Completed | 4 | 464 | US | Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489, Methylphenidate Hydrochloride, OROS-MPH, Concerta, Placebo | Shire | Attention-deficit/Hyperactivity Disorder | 01/14 | 01/14 | | |
| Completed | 4 | 549 | Europe, Canada, US | Lisdexamfetamine dimesylate, SPD489, Vyvanse, LDX, Methylphenidate Hydrochloride, Concerta, OROS-MPH, Placebo | Shire | Attention-deficit/Hyperactivity Disorder | 05/14 | 05/14 | | |
NCT02352051: Effects of Atx and Oros-mph on Executive Functions |
|
|
| Completed | 4 | 43 | RoW | Atomoxetine, STRATTERA, methylphenidate, CONCERTA | TC Erciyes University | Executive Dysfunction | 10/14 | 10/14 | | |
NCT01940978: A Study of Combination Therapy in Children With ADHD |
|
|
| Completed | 4 | 99 | US | Methylphenidate ER, Concerta, Cyproheptadine, Periactin | Douglas Sears | ADHD, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Mental Disorders Diagnosed in Childhood, Attention Deficit and Disruptive Behavior Disorders | 03/15 | 03/15 | | |
2015-001081-26: Lab School Day Study for CONCERTA of Older Children with ADHD |
|
|
| | 4 | 78 | US | CONCERTA, Capsule, CONCERTA | Ortho-McNeil Janssen Scientific Affairs LLC, Ortho-McNeil Janssen Scientific Affairs | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-001084-39: An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| | 4 | 125 | RoW | CONCERTA, Capsule, CONCERTA | Janssen Korea Ltd, Janssen Korea Ltd | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-001217-27: An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| | 4 | 142 | RoW | CONCERTA, Capsule, CONCERTA | Janssen Korea Ltd, Janssen Korea Ltd | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-001218-92: A study to evaulate the most favourable treatment dose in childrens and adolescents with Attention-Deficit Hyperactivity Disorder |
|
|
| | 4 | 145 | RoW | CONCERTA, Capsule, CONCERTA | Janssen Korea Ltd, Janssen Korea Ltd | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-001216-35: The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| | 4 | 296 | RoW | CONCERTA, Capsule, CONCERTA | Johnson & Johnson Taiwan Ltd, Johnson & Johnson Taiwan Ltd | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-001070-18: A study to determine effective and tolerable titration scheme for OROS-Methylphenidate in Children with Attention-deficit hyperactivity disorder |
|
|
| | 4 | 520 | RoW | CONCERTA, Prolonged-release capsule, CONCERTA | Janssen-Cilag Taiwan, Janssen-Cilag Taiwan | Attention Deficit Hyperactivity Disorder, being hyperactive and/or inattentive, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Completed | 4 | 222 | US | Methylphenidate, Concerta Extended Release, Ritalin, Intensive reading instruction, Parent Training, Mixed Salt Amphetamine, Adderall Extended Release (XR), Atomoxetine, Strattera, Guanfacine, Intuniv | The University of Texas Health Science Center, Houston, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Children's Hospital Medical Center, Cincinnati | Attention Deficit Hyperactivity Disorder, Reading Disabilities | 06/15 | 06/15 | | |
2014-002002-20: A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate |
|
|
| Ongoing | 4 | 120 | Europe | Capsule, hard, Concerta | UMCG, ZonMw, Shire | attention-deficit/hyperactivity disorder, attention-deficit/hyperacitivity disorder (ADHD), Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04] | | | | |
NCT02074228: Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD |
|
|
| Unknown status | 4 | 120 | RoW | Methylphenidate (Concerta) | National Taiwan University Hospital, National Science Council, Taiwan | Attention-deficit/Hyperactivity Disorder | 07/15 | 07/15 | | |
2005-003295-38: Vergleich der Wirksamkeit von Medikinet retard mit Concerta bei Kindern mit ADHS |
|
|
| Completed | 4 | 122 | Europe | Medikinet retard 10 mg, | Medice Arzneimittel Pütter GmbH & Co. KG | Hyperkinetische Störung bzw. Aufmerksamkeitsdefizit/Hyperaktivitätsstörung (ADHS) | | 04/09 | | |
2009-011887-12: Evaluation of ADHD from childhood to adolescence- impact of medical treatment on autonomic nervous system parameters |
|
|
| Ongoing | 4 | 100 | Europe | Methylphenidate( Ritalin®, Medikinet®, Equasym® or Concerta®), Atomoxetin (Strattera ®) | Praxis Prof. Koenig | ADHD is a neurobehavioral developmental disorder which affects about 5% of children. In our clinical trial designed we would like to examine whether medical treatment with stimulants has an influence on autonomic nervous system parameters. Therefore children already taking their medication will be examined while ease and exertion. Children taking part must not suffer from any kind of cardiovascular desease. | | | | |
2010-020014-28: Pharmacokinetics in Plasma and Saliva of a Single Dose Immediate- or Extended Release Methylphenidate in Healthy Volunteers. |
|
|
| Completed | 4 | 12 | Europe | Ritalin, Concerta, Ritalin, Concerta | Centre for Human Drug Research | N/A; pharmacokinetic study.Methylphenidate is indicated in ADHD and narcolepsia. | | | | |
2012-000517-37: Clinical Trial of Concerta for the treatment of ADHD in adult offenders |
|
|
| Ongoing | 4 | 100 | Europe | Concerta XL, Concerta XL, Concerta XL | King\'s College London, South London and Maudsley NHS Foundation Trust, National Institute for Health Research, Kings College London, Forensic and Neurodevelopmental Science Department (Prof Declan Murphy) | Attention deficit hyperactivity disorder (ADHD) | | | | |
NCT02204410: Omega-3 Supplementation to ADHD Medication in Children |
|
|
| Completed | 4 | 21 | US | Omega-3 Fatty Acid, Fish Oil, Nordic Naturals Pro-Omega Junior Omega-3 Fatty Acid, Nordic Omega-3 Fishies, ADHD Medication, Stimulant, Concerta, Ritalin, Focalin, Vyvanse, Adderall, Dexedrine, Amphetamine, Methylphenidate, Stratterra, Tenex | Massachusetts General Hospital | Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | 05/16 | 08/16 | | |
2015-004271-78: Randomised controlled trial of the short term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder |
|
|
| Ongoing | 4 | 200 | Europe | Concerta XL 18 mg prolonged-release tablets, Tablet, Concerta XL | King's College London, NIHR EME | Attention Deficit Hyperactivity Disorder (ADHD), ADHD, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT02623114: Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers |
|
|
| Unknown status | 4 | 400 | RoW | methylphenidate, concerta, metadate, penid, atomoxetine, strattera | Seoul National University Childrens Hospital | Attention-deficit/Hyperactivity Disorder | 08/16 | 03/17 | | |
NCT01933217: Methylphenidate for Attention Problems After Pediatric TBI |
|
|
| Completed | 4 | 26 | US | Methylphenidate, Concerta, Placebo | Children's Hospital Medical Center, Cincinnati | Traumatic Brain Injury, TBI, ADHD | 08/16 | 08/16 | | |
2017-000368-14: A clinical trial of methylphenidate and lisdexamphetamine treatment in adults with attention-deficit hyperactivity disorder En jämförande studie av metylfenidat och lisdexamfetamine hos vuxna personer med ADHD |
|
|
| Terminated | 4 | 120 | Europe | Elvanse, Concerta, Capsule, hard, Tablet, Elvanse, Concerta | Sahlgrenska Univerisity Hospital Gothenburg, Sahlgrenska University Hospital | Attention Deficit Hyperactivity Disorder aktivitets- och uppmärksamhetsstörning, Attention deficit hyperactivity disorder is a mental disorder characterized by problems paying attention, excessive activity, or difficulty controlling behavior ADHD är en neuropsykiatrisk funktionsnedsättning som utmärks av nedsatta exekutiva förmågor, exempelvis bristande förmåga att kontrollera uppmärksamheten och/eller hyperaktivitet., Psychiatry and Psychology [F] - Behaviours [F01] | | | | |
NCT02063945: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders |
|
|
| Terminated | 4 | 5 | RoW | Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Concerta, Risperidone, Risperdal | Sheba Medical Center | Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder | 02/18 | 02/18 | | |
NCT01678209: Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach |
|
|
| Completed | 4 | 127 | US | fMRI scans, Atomoxetine arm, Strattera, ATX, Methylphenidate arm, Concerta, MPH | Icahn School of Medicine at Mount Sinai, National Institute of Mental Health (NIMH) | Attention Deficit Hyperactivity Disorder, ADHD | 04/18 | 04/18 | | |
| Completed | 4 | 267 | US | Methylphenidate, Concerta | Florida International University | Attention-deficit/Hyperactivity Disorder | 05/18 | 03/20 | | |
| Unknown status | 4 | 1344 | Europe, US, RoW | Short Acting Methylphenidate, • Ritalin, • Ritalina, • Attenta, • Methylin, • Penid, • Rubifen, *Consider treatment directions above or as physician directed as per usual care., Long Acting Methylphenidate, • Concerta, • Metadate CD, • Methylin ER, • Ritalin LA, • Ritalin Sustained-Release | BRC Operations Pty. Ltd. | Attention Deficit/Hyperactivity Disorder | 12/19 | 12/19 | | |
| Completed | 4 | 204 | US | OROS-Methylphenidate (MPH), Concerta | Children's Hospital Medical Center, Cincinnati, Seattle Children's Hospital | ADHD | 06/20 | 06/21 | | |
NCT02566824: Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder |
|
|
| Unknown status | 4 | 216 | Canada | Cognitive Behavioural & Skills Training, Supportive Group Therapy, Treatment as Usual - community resources, Methylphenidate or amphetamine product, Ritalin, Concerta, Biphentin, Dexedrine, Adderall XR, Vyvanse | McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR) | Attention Deficit Hyperactivity Disorder | 08/20 | 10/20 | | |
RE-DAX, NCT04507204: Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Terminated | 4 | 267 | US | Adhansia XR, Methylphenidate hydrochloride (HCl) extended release, Concerta, Methylphenidate hydrochloride (HCl) | Purdue Pharma LP | Attention-Deficit/Hyperactivity Disorder | 12/21 | 01/22 | | |
NCT05974241: Irritability in Children With ADHD and Emotion Dysregulation |
|
|
| Completed | 4 | 36 | RoW | Methylphenidate, aripiprazole, and combination, Ritalin/Concerta, Abilify, and combination | Tri-Service General Hospital | Irritable Mood, ADHD | 04/22 | 04/22 | | |
ChiCTR2100047663: Study on the effect of methylphenidate on brain function and prediction of therapeutic effect in children with ADHD |
|
|
| Recruiting | 4 | 50 | | Concerta vs placebo ;None | Peking University Sixth Hospital; Peking University Sixth Hospital, Self-financing | Attention-Deficit/Hyperactivity Disorder | | | | |
NCT04283604: The Effects of a Single Dose of Methylphenidate on Motor Performance |
|
|
| Recruiting | 4 | 200 | RoW | MPH, Concerta, Ritalin | Loewenstein Hospital, Tel Aviv University, Wingate Institute | ADHD | 03/24 | 03/24 | | |
| Recruiting | 4 | 20 | RoW | Methylphenidate Hydrochloride, Ritalin 10 tablets, Placebo, Methylphenidate hydrochloride, Ritalin LA Long acting capsules, Methylphenidate Hydrochloride 18 MG, Concerta, Dexamphetamine sulfate, Aspen Dexamfetamine Tablets | Monash Medical Centre, Monash University | Fetal Alcohol Spectrum Disorders | 04/23 | 07/23 | | |
| Recruiting | 4 | 10 | US | Stimulant, Adderall, Concerta, Aptensio, Daytrana, Metadate, Quillivant, Ritalin, Focalin, Vyvanse | Matthew J O'Brien, PhD, BCBA-D | Attention Deficit Hyperactivity Disorder, Problem Behavior | 01/25 | 01/25 | | |
| Recruiting | 4 | 226 | US | Methylphenidate, Concerta, Ritalin, Daytrana, Aptensio XR, Metadate CD, Methylin, Quillivant XR, Jornay PM, Adhansia XR, Cotempla, Placebo, sugar pill, lactose | VA Office of Research and Development, VA New York Harbor Healthcare System, Portland VA Medical Center, Miami VA Healthcare System, VA Boston Healthcare System | Epilepsy | 09/27 | 09/27 | | |
